Key result
Angiopoietin 1 over-expression attenuated renal tubular necrosis and endothelial loss after ischemic reperfusion injury, whereas its knockout delayed renal function recovery and impaired neoangiogenesis.
Why the study?
Endothelial damage from ischemia reperfusion injury (IRI) disrupts the microvasculature, which might be influenced by angiopoietin 1 via its effects on the endothelium.
Does angiopoietin 1 manipulation influence renal damage and recovery in mice with ischemic reperfusion renal injury?
Does angiopoietin 1 manipulation influence renal damage and recovery in mice with ischemic reperfusion renal injury?
Manipulation of angiopoietin 1 modulates endothelium survival and regeneration, representing a potential therapeutic approach for ischemic kidney injury.
Angiopoietin-1 modulation may attenuate ischemic renal injury in mice; hypothesis-generating for human AKI therapies pending clinical translation.
BACKGROUND: Damage to the endothelium due to ischemia reperfusion injury (IRI) leads to a disruption of the microvasculature, which could be influenced by angiopoietin 1 via its effects on endothelium. We investigated the physiological and therapeutic roles of angiopoietin 1 in renal IRI using angiopoietin 1 knockout and over-expression mice. METHODS: Renal IRI was induced by clamping the right renal artery seven days after left uninephrectomy for 25 min followed by reperfusion. A whole body angiopoietin 1 knockout was achieved by induction with tamoxifen. The renal tubule over-expression of angiopoietin 1 was induced by doxycycline. RESULTS: In the normal mice, the renal expression of angiopoietin 1 increased 7 days to 14 days after IRI. The angiopoietin 1 knockout caused a delay in the recovery of renal function, less tubular regeneration and more residual tubular necrosis. The endothelial density was lower and the VE-cadherin protein loss was greater in the knockout mice. The over-expression of angiopoietin 1 attenuated the tubular necrosis and renal function impairment 1 and 3 days after IRI. The loss of the endothelium was ameliorated in the over-expression mice. This protective effect was associated with the up-regulation of the gene expression of epidermal growth factor, hepatocyte growth factor, and insulin like growth factor-1 and less tubular apoptosis. The over-expression of angiopoietin 1 stimulated tumor necrosis factor-α, C-C chemokine receptor type 2 and CX3C chemokine receptor 1 inflammatory gene expression, but did not influence macrophage infiltration. CONCLUSIONS: Altogether, the augmentation and downregulation of angiopoietin 1 attenuated renal damage and impaired renal recovery, respectively, by influencing the survival/regeneration of the endothelium. The manipulation of angiopoietin 1 represents a novel therapeutic approach for the treatment of ischemic kidney injury.
No takes yet. Share an insight, caveat, or question.
Chiang et al. (2019) studied Ischemic reperfusion renal injury (Acute kidney injury). Angiopoietin 1 knockout and over-expression vs. Control littermate mice was evaluated on Renal function recovery, tubular regeneration, and endothelial survival. Angiopoietin 1 over-expression attenuated renal tubular necrosis and endothelial loss after ischemic reperfusion injury, whereas its knockout delayed renal function recovery and impaired neoangiogenesis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: